Artykuły w czasopismach na temat „Preclinical tumor models”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Preclinical tumor models”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Varticovski, L., M. G. Hollingshead, M. R. Anver, A. I. Robles, J. E. Green, K. W. Hunter, G. Merlino i in. "Preclinical testing using tumors from genetically engineered mouse mammary models". Journal of Clinical Oncology 24, nr 18_suppl (20.06.2006): 10067. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.10067.
Pełny tekst źródłaKlenner, Marbod, Pia Freidel, Mariella G. Filbin i Alexander Beck. "DIPG-39. New preclinical models for Diffuse Midline Glioma". Neuro-Oncology 24, Supplement_1 (1.06.2022): i27. http://dx.doi.org/10.1093/neuonc/noac079.096.
Pełny tekst źródłaCosta, Alice, Livia Gozzellino, Margherita Nannini, Annalisa Astolfi, Maria Abbondanza Pantaleo i Gianandrea Pasquinelli. "Preclinical Models of Visceral Sarcomas". Biomolecules 13, nr 11 (6.11.2023): 1624. http://dx.doi.org/10.3390/biom13111624.
Pełny tekst źródłaLlaguno-Munive, Monserrat, Wilberto Villalba-Abascal, Alejandro Avilés-Salas i Patricia Garcia-Lopez. "Near-Infrared Fluorescence Imaging in Preclinical Models of Glioblastoma". Journal of Imaging 9, nr 10 (6.10.2023): 212. http://dx.doi.org/10.3390/jimaging9100212.
Pełny tekst źródłaSewduth, Raj N., i Konstantina Georgelou. "Relevance of Carcinogen-Induced Preclinical Cancer Models". Journal of Xenobiotics 14, nr 1 (5.01.2024): 96–109. http://dx.doi.org/10.3390/jox14010006.
Pełny tekst źródłaRoosen, Mieke, Chris Meulenbroeks, Phylicia Stathi, Joris Maas, Julie Morscio, Jens Bunt i Marcel Kool. "BIOL-11. PRECLINICAL MODELLING OF PEDIATRIC BRAIN TUMORS USING ORGANOID TECHNOLOGY". Neuro-Oncology 25, Supplement_1 (1.06.2023): i8. http://dx.doi.org/10.1093/neuonc/noad073.030.
Pełny tekst źródłaStripay, Jennifer L., Thomas E. Merchant, Martine F. Roussel i Christopher L. Tinkle. "Preclinical Models of Craniospinal Irradiation for Medulloblastoma". Cancers 12, nr 1 (5.01.2020): 133. http://dx.doi.org/10.3390/cancers12010133.
Pełny tekst źródłaSitta, Juliana, Pier Paolo Claudio i Candace M. Howard. "Virus-Based Immuno-Oncology Models". Biomedicines 10, nr 6 (18.06.2022): 1441. http://dx.doi.org/10.3390/biomedicines10061441.
Pełny tekst źródłaOrtiz, Michael Vincent, Armaan Siddiquee, Daoqi You, Prabhjot Singh Mundi, Lianna Marks, Kristina Guillan, Daniel Diolaiti i in. "Preclinical evaluation of XPO1 inhibition in Wilms tumors." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): 3580. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.3580.
Pełny tekst źródłaBella, Ángela, Claudia Augusta Di Trani, Myriam Fernández-Sendin, Leire Arrizabalaga, Assunta Cirella, Álvaro Teijeira, José Medina-Echeverz, Ignacio Melero, Pedro Berraondo i Fernando Aranda. "Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications". Cancers 13, nr 5 (25.02.2021): 963. http://dx.doi.org/10.3390/cancers13050963.
Pełny tekst źródłaMahmoudian, Reihaneh Alsadat, Moein Farshchian, Fatemeh Fardi Golyan, Parvaneh Mahmoudian, Ali Alasti, Vahid Moghimi, Mina Maftooh i in. "Preclinical tumor mouse models for studying esophageal cancer". Critical Reviews in Oncology/Hematology 189 (wrzesień 2023): 104068. http://dx.doi.org/10.1016/j.critrevonc.2023.104068.
Pełny tekst źródłaTada, Takuya, Thomas D. Norton, Rebecca Leibowitz i Nathaniel R. Landau. "Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models". Journal for ImmunoTherapy of Cancer 12, nr 4 (kwiecień 2024): e008761. http://dx.doi.org/10.1136/jitc-2023-008761.
Pełny tekst źródłaBaniahmad, Aria. "Tumor spheroids and organoids as preclinical model systems". Medizinische Genetik 33, nr 3 (1.09.2021): 229–34. http://dx.doi.org/10.1515/medgen-2021-2093.
Pełny tekst źródłaTellez-Gabriel, Marta, Denis Cochonneau, Marie Cadé, Camille Jubelin, Marie-Françoise Heymann i Dominique Heymann. "Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine". Cancers 11, nr 1 (24.12.2018): 19. http://dx.doi.org/10.3390/cancers11010019.
Pełny tekst źródłaEhrenberg, Karl Roland, Jianpeng Gao, Felix Oppel, Stephanie Frank, Na Kang, Sebastian M. Dieter, Friederike Herbst i in. "Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer". Cells 8, nr 2 (10.02.2019): 142. http://dx.doi.org/10.3390/cells8020142.
Pełny tekst źródłaPinto, Bárbara, Ana C. Henriques, Patrícia M. A. Silva i Hassan Bousbaa. "Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research". Pharmaceutics 12, nr 12 (6.12.2020): 1186. http://dx.doi.org/10.3390/pharmaceutics12121186.
Pełny tekst źródłaDavy, Mélodie, Laurie Genest, Christophe Legrand, Océane Pelouin, Guillaume Froget, Vincent Castagné i Tristan Rupp. "Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models". Cancers 15, nr 18 (8.09.2023): 4478. http://dx.doi.org/10.3390/cancers15184478.
Pełny tekst źródłaKoptyra, Mateusz, Valerie Baubet, David Beale, Luke Patterson, Ian Biluck, Madison Hollawell, Christopher M. Beck i in. "MODL-30. Children’s Brain Tumor Network preclinical tumor models development and sharing platform: collaborative model empowering pediatric brain tumor discovery and global research." Neuro-Oncology 24, Supplement_1 (1.06.2022): i175—i176. http://dx.doi.org/10.1093/neuonc/noac079.653.
Pełny tekst źródłaMohr, Hermine, i Natalia S. Pellegata. "Animal models of MEN1". Endocrine-Related Cancer 24, nr 10 (październik 2017): T161—T177. http://dx.doi.org/10.1530/erc-17-0249.
Pełny tekst źródłaMinami, Jenna, Nicholas Bayley, Christopher Tse, Henan Zhu, Danielle Morrow, William Yong, Linda Liau, Timothy Cloughesy, Thomas Graeber i David Nathanson. "TAMI-06. PRECLINICAL MODELS REVEAL BRAIN-MICROENVIRONMENT SPECIFIC METABOLIC DEPENDENCIES IN GLIOBLASTOMA". Neuro-Oncology 22, Supplement_2 (listopad 2020): ii214. http://dx.doi.org/10.1093/neuonc/noaa215.895.
Pełny tekst źródłaHollawell, Madison, Valerie Baubet, David Beale, Luke Patterson, Ian Biluck, Ciana Anthony, Peeyush Goel i in. "BIOL-22. CHILDREN’S BRAIN TUMOR NETWORK PRECLINICAL TUMOR MODELS DEVELOPMENT AND SHARING PLATFORM: COLLABORATIVE MODEL EMPOWERING PEDIATRIC BRAIN TUMOR DISCOVERY AND GLOBAL RESEARCH". Neuro-Oncology 25, Supplement_1 (1.06.2023): i10—i11. http://dx.doi.org/10.1093/neuonc/noad073.041.
Pełny tekst źródłaHansson, Karin, Katarzyna Radke, Kristina Aaltonen, Jani Saarela, Adriana Mañas, Jonas Sjölund, Emma M. Smith i in. "Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma". Science Translational Medicine 12, nr 562 (23.09.2020): eaba4434. http://dx.doi.org/10.1126/scitranslmed.aba4434.
Pełny tekst źródłaMinami, Jenna, Nicholas Bayley, Christopher Tse, Henan Zhu, Danielle Morrow, William Yong, Linda Liau, Timothy F. Cloughesy, Thomas Graeber i David A. Nathanson. "ETMM-02. PRECLINICAL MODELS REVEAL BRAIN-MICROENVIRONMENT SPECIFIC METABOLIC DEPENDENCIES IN GLIOBLASTOMA". Neuro-Oncology Advances 3, Supplement_1 (1.03.2021): i14. http://dx.doi.org/10.1093/noajnl/vdab024.058.
Pełny tekst źródłaSgouros, George, Robert F. Hobbs i Diane S. Abou. "The Role of Preclinical Models in Radiopharmaceutical Therapy". American Society of Clinical Oncology Educational Book, nr 34 (maj 2014): e121-e125. http://dx.doi.org/10.14694/edbook_am.2014.34.e121.
Pełny tekst źródłaDobson, Tara, i Vidya Gopalakrishnan. "Preclinical Models of Pediatric Brain Tumors—Forging Ahead". Bioengineering 5, nr 4 (2.10.2018): 81. http://dx.doi.org/10.3390/bioengineering5040081.
Pełny tekst źródłaForde, Patrick F., Mira Sadadcharam, Michael G. Bourke, Thomas A. Conway, Shane R. Guerin, Marcel de Kruijf, Gerald C. O’Sullivan, Joseph Impellizeri, Anthony J. P. Clover i Declan M. Soden. "Preclinical evaluation of an endoscopic electroporation system". Endoscopy 48, nr 05 (4.04.2016): 477–83. http://dx.doi.org/10.1055/s-0042-101343.
Pełny tekst źródłaChen, Stephen R., Frederick F. Lang i Peter Kan. "Preclinical animal brain tumor models for interventional neuro-oncology". Journal of NeuroInterventional Surgery 14, nr 5 (12.04.2022): neurintsurg—2022–018968. http://dx.doi.org/10.1136/neurintsurg-2022-018968.
Pełny tekst źródłaWu, Jianrong, i Peter J. Houghton. "Assessing Cytotoxic Treatment Effects in Preclinical Tumor Xenograft Models". Journal of Biopharmaceutical Statistics 19, nr 5 (7.08.2009): 755–62. http://dx.doi.org/10.1080/10543400903105158.
Pełny tekst źródłaBanerjee, Sulagna, Venugopal Thayanithy, Veena Sangwan, Tiffany N. Mackenzie, Ashok K. Saluja i Subbaya Subramanian. "Minnelide reduces tumor burden in preclinical models of osteosarcoma". Cancer Letters 335, nr 2 (lipiec 2013): 412–20. http://dx.doi.org/10.1016/j.canlet.2013.02.050.
Pełny tekst źródłaVitale, Giovanni, Silvia Carra, Ylenia Alessi, Federica Campolo, Carla Pandozzi, Isabella Zanata, Annamaria Colao i Antongiulio Faggiano. "Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies". International Journal of Molecular Sciences 24, nr 4 (10.02.2023): 3610. http://dx.doi.org/10.3390/ijms24043610.
Pełny tekst źródłaMcCloskey, Curtis, Galaxia Rodriguez, Kristianne Galpin i Barbara Vanderhyden. "Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics". Cancers 10, nr 8 (26.07.2018): 244. http://dx.doi.org/10.3390/cancers10080244.
Pełny tekst źródłaDondossola, Eleonora, Andrey S. Dobroff, Serena Marchiò, Marina Cardó-Vila, Hitomi Hosoya, Steven K. Libutti, Angelo Corti, Richard L. Sidman, Wadih Arap i Renata Pasqualini. "Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors". Proceedings of the National Academy of Sciences 113, nr 8 (8.02.2016): 2223–28. http://dx.doi.org/10.1073/pnas.1525697113.
Pełny tekst źródłaHicks, William H., Cylaina E. Bird, Jeffrey I. Traylor, Diana D. Shi, Tarek Y. El Ahmadieh, Timothy E. Richardson, Samuel K. McBrayer i Kalil G. Abdullah. "Contemporary Mouse Models in Glioma Research". Cells 10, nr 3 (23.03.2021): 712. http://dx.doi.org/10.3390/cells10030712.
Pełny tekst źródłaErnst, Kati, Konstantin Okonechnikov, Laura von Soosten, Nina Hofmann, Norman Mack, Benjamin Schwalm, Robert J. Wechsler-Reya i in. "BIOL-07. DISTINCTIVE FEATURES OF HIGH-GRADE GLIOMA MOUSE MODELS REVEALED BY SINGLE-NUCLEUS RNA-SEQUENCING GUIDE PRE-CLINICAL MODEL SELECTION". Neuro-Oncology 25, Supplement_1 (1.06.2023): i7. http://dx.doi.org/10.1093/neuonc/noad073.026.
Pełny tekst źródłaChauhan, Aman, Piotr Rychahou, Tadahide Izumi, Susanne M. Arnold, Lowell Brian Anthony, Mark Evers i Charles Kunos. "Antitumor efficacy of M3814 as a radiation sensitizer in neuroendocrine tumor (NET) preclinical models." Journal of Clinical Oncology 37, nr 15_suppl (20.05.2019): e15699-e15699. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e15699.
Pełny tekst źródłaHaskell-Mendoza, Aden, Lucas Wachsmuth i Peter Fecci. "LMAP-09 RECAPITULATING LASER INTERSTITIAL THERMAL THERAPY IN PRECLINICAL BRAIN TUMOR MODELS". Neuro-Oncology Advances 5, Supplement_3 (1.08.2023): iii11. http://dx.doi.org/10.1093/noajnl/vdad070.040.
Pełny tekst źródłaLee, Jung Woo, Jia Kim, Youngjae Shin, Byung Hoon Chi, Jung Hoon Kim i Se Young Choi. "Patient-Specific Tumor Microenvironment Models". Korean Journal of Urological Oncology 19, nr 4 (30.11.2021): 197–222. http://dx.doi.org/10.22465/kjuo.2021.19.4.197.
Pełny tekst źródłaKalra, Jessica, Jennifer Baker, Justin Song, Alastair Kyle, Andrew Minchinton i Marcel Bally. "Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model". International Journal of Molecular Sciences 22, nr 12 (13.06.2021): 6336. http://dx.doi.org/10.3390/ijms22126336.
Pełny tekst źródłaSpoormans, Kaat, Melissa Crabbé, Lara Struelens, Marijke De Saint-Hubert i Michel Koole. "A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT)". Pharmaceutics 14, nr 10 (22.09.2022): 2007. http://dx.doi.org/10.3390/pharmaceutics14102007.
Pełny tekst źródłaBarachini, Serena, Mariangela Morelli, Orazio Santo Santonocito i Chiara Maria Mazzanti. "Preclinical glioma models in neuro-oncology: enhancing translational research". Current Opinion in Oncology 35, nr 6 (1.09.2023): 536–42. http://dx.doi.org/10.1097/cco.0000000000000997.
Pełny tekst źródłaKemper, Kristel, Ellis Gielen, Peter Boross, Mischa Houtkamp, Theo S. Plantinga, Stefanie AH de Poot, Saskia M. Burm i in. "Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models". Life Science Alliance 5, nr 11 (8.09.2022): e202201481. http://dx.doi.org/10.26508/lsa.202201481.
Pełny tekst źródłaGolebiewska, Anna, Ann-Christin Hau, Anais Oudin, Daniel Stieber, Yahaya A. Yabo, Yong-Jun Kwon, Barbara Klink i in. "TMOD-08. PRIMARY AND RECURRENT GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS (PDOX) REPRESENT RELEVANT PATIENT AVATARS FOR PRECISION MEDICINE". Neuro-Oncology 22, Supplement_2 (listopad 2020): ii229. http://dx.doi.org/10.1093/neuonc/noaa215.959.
Pełny tekst źródłaYu, Rong, Ewetse Paul Maswikiti, Yang Yu, Lei Gao, Chenhui Ma, Huanhuan Ma, Xiaobo Deng, Na Wang, Bofang Wang i Hao Chen. "Advances in the Application of Preclinical Models in Photodynamic Therapy for Tumor: A Narrative Review". Pharmaceutics 15, nr 1 (5.01.2023): 197. http://dx.doi.org/10.3390/pharmaceutics15010197.
Pełny tekst źródłaSaito, Yasuyuki, Afroj Tania, Satomi Komori, Tomoko Takai, Okechi S. Oduori, Takenori Kotani, Yohei Funakoshi i in. "Preclinical Evaluation of the Efficacy of Human Sirpα Antibodies for B-Cell Lymphoma Immunotherapy in Humanized Mouse Models". Blood 142, Supplement 1 (28.11.2023): 1646. http://dx.doi.org/10.1182/blood-2023-181926.
Pełny tekst źródłaZhu, Menghan, Nan Jia, Yanyan Nie, Jun Chen, Yahui Jiang, Tianjiao Lv, Yuanyuan Li, Liangqing Yao i Weiwei Feng. "Establishment of Patient-Derived Tumor Xenograft Models of High-Risk Endometrial Cancer". International Journal of Gynecologic Cancer 28, nr 9 (listopad 2018): 1812–20. http://dx.doi.org/10.1097/igc.0000000000001365.
Pełny tekst źródłaMatei, Daniela. "Abstract IA018: Epigenome targeting in ovarian cancer: preclinical models to clinic". Cancer Research 84, nr 5_Supplement_2 (4.03.2024): IA018. http://dx.doi.org/10.1158/1538-7445.ovarian23-ia018.
Pełny tekst źródłaIaia, Ilenia, Loretta Gammaitoni, Giulia Cattaneo, Lidia Giraudo, Chiara Donini, Erika Fiorino, Luca Primo i in. "Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models". Cancers 13, nr 10 (11.05.2021): 2302. http://dx.doi.org/10.3390/cancers13102302.
Pełny tekst źródłaGrausam, Katie, David Rincon Fernandez Pacheco, Emily Hatanaka, Stephen Shiao i Joshua Breunig. "MODL-34. A SERIES OF EGFR-MUTANT MODELS OF GLIOBLASTOMA THAT RECAPITULATES PATIENT TUMOR HETEROGENEITY AND RESPONSE TO TREATMENT". Neuro-Oncology 25, Supplement_5 (1.11.2023): v306. http://dx.doi.org/10.1093/neuonc/noad179.1185.
Pełny tekst źródłaOdunsi, Adekunle, A. J. Robert McGray, Anthony Miliotto, Yali Zhang, Jianming Wang, Adebukola Abiola, Cheryl Eppolito i Ruea-Yea Huang. "Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies". Journal for ImmunoTherapy of Cancer 8, nr 2 (listopad 2020): e001237. http://dx.doi.org/10.1136/jitc-2020-001237.
Pełny tekst źródłaFranklin, M., M. Thayer, D. Draper, D. Saims i S. Wise. "Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models". European Journal of Cancer 69 (grudzień 2016): S97. http://dx.doi.org/10.1016/s0959-8049(16)32887-8.
Pełny tekst źródła